Objective: We aimed to assess the impact of ureteral access sheath (UAS) size on intrarenal pressure (IRP) using LithoVue Elite (LVE) ureteroscope (Boston Scientific) during lithotripsy and to identify factors contributing to increased IRP.
Methods: A single-arm prospective study was conducted on 21 consecutive patients who underwent ureteroscopic lithotripsy using the LVE at a single center between April 2023 and April 2024. 11/13 Fr or 13/15 Fr UAS was placed in all cases based on the physician's discretion. We analyzed baseline, median, and maximum IRPs and factors associated with increased IRP (≥ 30 mmHg).
Results: Median age was 61 (IQR: 48-66) years. Baseline, median, and maximum IRPs were 11 (IQR: 5-16), 32 (IQR: 18-67), and 159 (IQR: 111-222) mmHg, respectively. 11/13Fr and 13/15Fr UAS were utilized in 10 and 11 patients, respectively, with no significant difference in patient demographics between the two groups. The baseline, median, and maximum IRPs were significantly lower in the 13/15Fr UAS group: 5 vs. 18.5 mmHg (p = 0.001), 21 vs. 57 mmHg (p = 0.02), and 111 vs 177.5 mmHg (p = 0.01). The use of 11/13 UAS was the factor associated with an increased median IRP (≥ 30 mmHg). Sex, comorbidities, the presence of hydronephrosis, stone location, the shape of the renal pelvis, and laser size were not.
Conclusions: Measurement and monitoring of IRPs using LVE during lithotripsy are technically feasible. Our study confirmed that the use of larger UAS can decrease IRP. Further investigation is needed to clarify the clinical impact of IRP during URS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11255-025-04430-4 | DOI Listing |
Pediatr Infect Dis J
March 2025
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
Background: Congenital cytomegalovirus is the leading cause of nongenetic sensorineural hearing loss. Treatment with (val)ganciclovir improves audiologic outcomes. Neutropenia is a common adverse event, but correlates that predict who will develop neutropenia have not been identified.
View Article and Find Full Text PDFPLoS One
March 2025
Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
Ferric carboxymaltose (FCM) is widely used to correct anemia and replenish iron stores rapidly, particularly in Western populations. However, lower doses of FCM are typically used in East Asia, with limited research on their effectiveness, especially in postpartum women. This randomized controlled trial aimed to assess the efficacy of low-dose FCM compared with oral ferrous sulfate in increasing postpartum hemoglobin (Hb) levels and replenishing iron stores in East Asian women.
View Article and Find Full Text PDFJ Neurooncol
March 2025
Neuro-Oncology Unit, Davidoff Cancer Center, Rabin Medical Center- Beilinson Hospital, Petach Tikva, Israel.
Purpose: To evaluate short and long-term efficacy of bevacizumab (Bev), for the treatment of radiation necrosis (RN) in patients with brain metastasis after stereotactic radiosurgery (SRS).
Methods: The database of a tertiary medical center was reviewed for all adult patients treated by Bev (from January 2018 to January 2023) for RN after having received SRS for BM. Clinical and MRI data were systematically collected at baseline, immediately after the completion of Bev treatment, and at 6, 12, and, when available, 24 months post-treatment.
Clin Rheumatol
March 2025
Laboratory of Human Anatomy, School of Basic Medicine Anatomy , Southwest Medical University, Xianglin Road, Longmatan District, Luzhou City, Sichuan Province, China.
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by complex immune interactions. Elucidating the causal relationships between blood cell perturbations, immune cell subsets, and RA can provide valuable insights into its pathogenesis.
Methods: This study employed bidirectional two-sample Mendelian Randomization (MR) to explore the causal effects of blood cell perturbations on RA risk, with a focus on immune cell mediation.
J Cutan Med Surg
March 2025
Division of Dermatology, Department of Medicine, Queen's University, Kingston, ON, Canada.
Background: For optimal control of atopic dermatitis (AD), patient education is essential to complement traditional therapy. Patient education has proven to benefit AD outcomes, but previous methods of delivery are costly and time-consuming.
Objective: To assess the effectiveness of a one-page pictorial education tool at improving AD quality of life (QoL) and disease severity.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!